In vivo studies of Gd-DTPA-monoclonal antibody and gd-porphyrins: potential magnetic resonance imaging contrast agents for melanoma.
about
Cobalt Zinc Ferrite Nanoparticles as a Potential Magnetic Resonance Imaging Agent: An In vitro Study.Development and characterization of an antibody-labeled super-paramagnetic iron oxide contrast agent targeting prostate cancer cells for magnetic resonance imaging.Selective delivery of therapeutic agents for the diagnosis and treatment of cancer.Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.Molecular magnetic resonance contrast agents for the detection of cancer: past and present.Recent trends in antibody-based oncologic imagingStrategies for the preparation of bifunctional gadolinium(III) chelators.Strategies for Target-Specific Contrast Agents for Magnetic Resonance ImagingThe detection limit of a Gd3+-based T1 agent is substantially reduced when targeted to a protein microdomain.Superparamagnetic iron oxide-C595: Potential MR imaging contrast agents for ovarian cancer detection.Magnetic resonance imaging (MRI) contrast agents for tumor diagnosis.Viral myocarditis--diagnosis, treatment options, and current controversies.In Vitro Evaluation of Gd(3+)-Anionic Linear Globular Dendrimer-Monoclonal Antibody: Potential Magnetic Resonance Imaging Contrast Agents for Prostate Cancer Cell Imaging.Novel MR imaging contrast agents for cancer detection.Detection of MUC1-expressing ovarian cancer by C595 monoclonal antibody-conjugated SPIONs using MR imaging.
P2860
Q30978421-54A6E9F5-D0C7-42F1-89B3-4682F6F1CBE6Q31161048-45DB9D4E-0E34-469E-AA0E-4820777D01BAQ33230098-FBD87E05-FBA9-43E4-B470-2CBA2AA438AFQ33847006-B43CFF82-B938-41EB-A486-05D3E6B6B343Q34823410-FBF57750-1FF5-4C12-95E9-D3242B3EE790Q35643425-AD1F7136-679E-4101-A005-1398FF87CFBDQ35777941-051189BF-3D25-4810-AB6A-43F36ABEBF25Q36517070-ADA610A3-00E6-4844-A10A-C370E5F60030Q36790262-69611C54-D529-4058-836F-AB8A432086B0Q37645860-A360F074-4A8E-4F93-8FA1-021E2E7AC835Q38090392-5565938D-3D96-47CC-8763-639BC0F974D1Q38551013-4B46DCDB-40B2-4EB3-AF52-9513AA81C707Q38881712-498314EA-E0AB-41CD-8911-7C9DA4543258Q42730346-C51A2E2D-135E-4BA0-8E49-C747B8F44F6AQ51773840-F80E4585-A8DD-4636-A0A4-66B195BA7E51
P2860
In vivo studies of Gd-DTPA-monoclonal antibody and gd-porphyrins: potential magnetic resonance imaging contrast agents for melanoma.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
In vivo studies of Gd-DTPA-mon ...... contrast agents for melanoma.
@ast
In vivo studies of Gd-DTPA-mon ...... contrast agents for melanoma.
@en
type
label
In vivo studies of Gd-DTPA-mon ...... contrast agents for melanoma.
@ast
In vivo studies of Gd-DTPA-mon ...... contrast agents for melanoma.
@en
prefLabel
In vivo studies of Gd-DTPA-mon ...... contrast agents for melanoma.
@ast
In vivo studies of Gd-DTPA-mon ...... contrast agents for melanoma.
@en
P2093
P2860
P356
P1476
In vivo studies of Gd-DTPA-mon ...... g contrast agents for melanoma
@en
P2093
P2860
P304
P356
10.1002/JMRI.1168
P577
2001-08-01T00:00:00Z